Abstract
<h3>To the Editor.—</h3> A letter in the December 23/30, 1988, issue of<i>JAMA</i>entitled "Imipenem Overprescribing" invited clinicians to contribute additional information regarding antibiotic use. The<i>term overprescribing</i>attracted our attention, since it is frequently bandied about in discussion of recently marketed antibiotics. We felt that it would be of interest to physicians and pharmacists to look at prescribing patterns of antibiotics, marketed within the last 7 years, from a national sample of hospitalized patients. <h3>Study. —</h3> We retrospectively reviewed data on parenteral antibiotic use from Pharmaceutical Data Services, Inc, of Scottsdale, Ariz. This computerized database compiles all patient discharge data (disease, procedures, and drug use) contributed from 50 geographically stratified hospitals in the United States. Presently, the database captures a 2% sample of national discharges. The hospitals' characteristics are as follows: teaching, 54%; nonteaching, 46%; nonprofit, 62%; church operated, 22%; for profit, 8%; government, 8%; 400 or more
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.